[Hymenoptera venom allergy]

Ugeskr Laeger. 2025 Jun 16;187(25):V09240593. doi: 10.61409/V09240593.
[Article in Danish]

Abstract

This review finds that diagnostics should only be performed in patients who might be candidates for venom immunotherapy (VIT). VIT is recommended for children and adults with documented sensitisation and systemic anaphylactic reactions (respiratory and/or circulatory symptoms) or reduced quality of life due to less severe reactions. VIT is not recommended for children with monosymptomatic urticaria. VIT should be continued for five years. Patients should carry an adrenaline autoinjector during insect season until a maintenance dose is reached.

Publication types

  • Review
  • English Abstract

MeSH terms

  • Adult
  • Anaphylaxis / diagnosis
  • Anaphylaxis / immunology
  • Anaphylaxis / therapy
  • Animals
  • Arthropod Venoms* / adverse effects
  • Arthropod Venoms* / immunology
  • Bee Venoms* / administration & dosage
  • Bee Venoms* / adverse effects
  • Bee Venoms* / immunology
  • Child
  • Desensitization, Immunologic / methods
  • Epinephrine / administration & dosage
  • Humans
  • Hymenoptera* / immunology
  • Hypersensitivity* / diagnosis
  • Hypersensitivity* / immunology
  • Hypersensitivity* / therapy
  • Insect Bites and Stings* / diagnosis
  • Insect Bites and Stings* / immunology
  • Insect Bites and Stings* / therapy
  • Wasp Venoms / immunology

Substances

  • Bee Venoms
  • Arthropod Venoms
  • Epinephrine
  • Wasp Venoms